RecruitingNCT05446155
BioMEL- Diagnostic and Prognostic Factors in Melanoma.
Studying Familial atypical multiple mole melanoma syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Region Skane
- Principal Investigator
- Kari Nielsen, Ass. Prof.Lund University Cancer Centre
- Intervention
- Imaging(diagnostic_test)
- Enrollment
- 2000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2028
Study locations (4)
- Helsingborg Hospital, Helsingborg, Skåne County, Sweden
- Kristianstad Hospital, Kristianstad, Skåne County, Sweden
- Lund University Hospital, Lund, Skåne County, Sweden
- Skåne University Hospital Malmö, Malmo, Skåne County, Sweden
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05446155 on ClinicalTrials.govOther trials for Familial atypical multiple mole melanoma syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06599619Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic NeviJohn Kirkwood
- RECRUITINGNCT04095195Registry of Subjects at Risk of Pancreatic CancerAssociazione Italiana per lo Studio del Pancreas
- RECRUITINGNCT00040352Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of MelanomaNational Cancer Institute (NCI)
See all trials for Familial atypical multiple mole melanoma syndrome →